Pompe Disease:
Gespeichert in:
Hauptverfasser: | , |
---|---|
Format: | Buch |
Sprache: | English |
Veröffentlicht: |
Bremen
UNI-MED
2021
|
Ausgabe: | 3rd edition |
Schriftenreihe: | UNI-MED Science
|
Schlagworte: | |
Online-Zugang: | Inhaltstext Inhaltsverzeichnis Inhaltsverzeichnis |
Beschreibung: | 160 Seiten Illustrationen 25 cm, 450 g |
ISBN: | 9783837424331 3837424332 |
Internformat
MARC
LEADER | 00000nam a2200000 c 4500 | ||
---|---|---|---|
001 | BV048488156 | ||
003 | DE-604 | ||
005 | 00000000000000.0 | ||
007 | t | ||
008 | 220927s2021 gw a||| |||| 00||| eng d | ||
015 | |a 22,N08 |2 dnb | ||
015 | |a 22,A23 |2 dnb | ||
016 | 7 | |a 1252089473 |2 DE-101 | |
020 | |a 9783837424331 |c Festeinband : EUR 4.95 (DE), EUR 5.10 (AT), CHF 9.40 (freier Preis) |9 978-3-8374-2433-1 | ||
020 | |a 3837424332 |9 3-8374-2433-2 | ||
024 | 3 | |a 9783837424331 | |
035 | |a (OCoLC)1347224938 | ||
035 | |a (DE-599)DNB1252089473 | ||
040 | |a DE-604 |b ger |e rda | ||
041 | 0 | |a eng | |
044 | |a gw |c XA-DE-HB | ||
049 | |a DE-19 | ||
082 | 0 | 4 | |a 616.3998 |2 23/ger |
084 | |8 1\p |a 610 |2 23sdnb | ||
100 | 1 | |a Reuser, Arnold J.J. |e Verfasser |0 (DE-588)1258294966 |4 aut | |
245 | 1 | 0 | |a Pompe Disease |c Arnold J.J. Reuser, Benedikt Schoser ; in collaboration with Atze J. Bergsma, Nadine A.M.E. van der Beek, Linda E.M. van den Berg, Alexander Broomfield, Esther Brusse [und weiteren] |
250 | |a 3rd edition | ||
264 | 1 | |a Bremen |b UNI-MED |c 2021 | |
300 | |a 160 Seiten |b Illustrationen |c 25 cm, 450 g | ||
336 | |b txt |2 rdacontent | ||
337 | |b n |2 rdamedia | ||
338 | |b nc |2 rdacarrier | ||
490 | 0 | |a UNI-MED Science | |
650 | 0 | 7 | |a Typ 2 |0 (DE-588)4326601-0 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Glykogenose |0 (DE-588)4157737-1 |2 gnd |9 rswk-swf |
653 | |a Morbus Pompe | ||
653 | |a Pompe Disease | ||
653 | |a lysosomal storage disorder | ||
653 | |a Morbus Pompe;Pompe Disease;lysosomal storage disorder | ||
689 | 0 | 0 | |a Glykogenose |0 (DE-588)4157737-1 |D s |
689 | 0 | 1 | |a Typ 2 |0 (DE-588)4326601-0 |D s |
689 | 0 | |5 DE-604 | |
700 | 1 | |a Schoser, Benedikt |e Verfasser |0 (DE-588)17274007X |4 aut | |
710 | 2 | |a UNI-MED Verlag AG |0 (DE-588)1065561733 |4 pbl | |
776 | 0 | 8 | |i Erscheint auch als |n Online-Ausgabe |a Reuser, Arnold J.J. |t Pompe Disease |b 3rd edition |d Bremen : UNI-MED Verlag AG, 2022 |h Online-Ressource, 161 Seiten, 64 Illustrationen |
780 | 0 | 0 | |i Vorangegangen ist |z 9783837413977 |
856 | 4 | 2 | |m X:MVB |q text/html |u http://deposit.dnb.de/cgi-bin/dokserv?id=40337a9757cc4b7cbf2dbceb2a6069ff&prov=M&dok_var=1&dok_ext=htm |3 Inhaltstext |
856 | 4 | 2 | |m B:DE-101 |q application/pdf |u https://d-nb.info/1252089473/04 |3 Inhaltsverzeichnis |
856 | 4 | 2 | |m DNB Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=033865687&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
999 | |a oai:aleph.bib-bvb.de:BVB01-033865687 | ||
883 | 2 | |8 1\p |a dnb |d 20220530 |q DE-101 |u https://d-nb.info/provenance/plan#dnb |
Datensatz im Suchindex
_version_ | 1804184446827495424 |
---|---|
adam_text | CONTENTS
13
CONTENTS
INTRODUCTION
17
1.1.
HISTORY
AND
TERMINOLOGY
...............................................................................................................
17
1.2.
POMPE
DISEASE
AS
LYSOSOMAL
GLYCOGEN
STORAGE
DISORDER
.........................................................
19
1.3.
EPIDEMIOLOGY
.................................................................................................................................
20
FROM
GENETIC
DEFECT
TO
CLINICAL
SYMPTOMS
23
2.1.
IN
GENERAL
.......................................................................................................................................
23
2.2.
FROM
THE
GAA
GENE
TO
FUNCTIONAL
LYSOSOMAL
GAA
....................................................................
24
2.2.1.
GAA
PRE-MRNA
SPLICING
...................................................................................................................
24
2.2.2.
TRANSLATION,
POST-TRANSLATIONAL
PROCESSING
AND
INTRACELLULAR
TRANSPORT
...........................................
25
2.3.
FROM
GAA
DEFICIENCY
TO
CELLULAR
PATHOLOGY
................................................................................
27
2.3.1.
GAA
DEFICIENCY
AND
ENSUING
CELLULAR
DAMAGE
......................................................................................
27
2.3.2.
RESCUE
OF
DAMAGED
MUSCLE
TISSUE
BY
SATELLITE
CELLS
......................................................................
29
2.4.
THE
GENOTYPE-PHENOTYPE
CORRELATION
........................................................................................
29
2.5.
THE
POMPE
VARIANT
DATABASE
AND
THE
POMPE
REGISTRY
.............................................................
32
2.6.
SUMMARY
........................................................................................................................................
33
AUTOPHAGY
AND
ITS
ROLE
IN
THE
PATHOGENESIS
OF
POMPE
DISEASE
38
3.1.
AUTOPHAGY:
BACKGROUND
..............................................................................................................
38
3.2.
AUTOPHAGY
IN
POMPE
DISEASE:
FOCUS
ON
SKELETAL
MUSCLE
..........................................................
40
3.3.
CONCLUSION
....................................................................................................................................
43
CLINICAL
SPECTRUM
46
4.1.
CLASSIC
INFANTILE
POMPE
DISEASE
....................................................................................................
46
4.1.1.
CLINICAL
PRESENTATION,
DIAGNOSIS,
AND
NATURAL
COURSE
OF
DISEASE
......................................................
46
4.1.2.
THE
NEW
PHENOTYPE
.........................................................................................................................
50
4.2.
CHILDHOOD
POMPE
DISEASE
...........................................................................................................
53
4.3.
ADULT
POMPE
DISEASE
...................................................................................................................
55
4.3.1.
CLINICAL
FINDINGS
................................................................................................................................
55
IB
DIAGNOSIS
65
5.1.
CLINICAL
CHEMISTRY
..........................................................................................................................
65
5.2.
MUSCLE
IMAGING
PROCEDURES
.........................................................................................................
66
5.2.1.
INFANTS
AND
CHILDREN
WITH
POMPE
DISEASE........................................................................................
66
5.2.2.
ADULT
POMPE
DISEASE
.......................................................................................................................
67
5.3.
EXAMINATION
OF
THE
CEREBRAL
VESSELS
............................................................................................
69
5.4.
EXAMINATION
OF
CARDIAC
FUNCTION
.................................................................................................
70
5.5.
EXAMINATION
OF
PULMONARY
FUNCTION
............................................................................................
71
5.6.
ELECTROMYOGRAPHIC
EXAMINATION
..................................................................................................
71
5.7.
MUSCLE
BIOPSY
...............................................................................................................................
71
5.8.
MEASUREMENT
OF
ENZYME
ACTIVITY
.................................................................................................
74
5.9.
DNA
ANALYSIS
.................................................................................................................................
75
14
CONTENTS
PRENATAL
DIAGNOSIS,
POPULATION
SCREENING
AND
COUNSELLING
82
6.1.
INTRODUCTION
....................................................................................................................................
82
6.2.
PRENATAL
DIAGNOSIS
.........................................................................................................................
82
6.3.
PREIMPLANTATION
GENETIC
TESTING
(PGT)
.......................................................................................
83
6.4.
NEWBORN
AND
POPULATION
SCREENING
............................................................................................
84
DIFFERENTIAL
DIAGNOSIS
OF
POMPE
DISEASE
88
7.1.
DIFFERENTIAL
DIAGNOSIS
OF
CLASSIC
INFANTILE
POMPE
DISEASE
..........................................................
88
7.2.
DIFFERENTIAL
DIAGNOSIS
OF
CHILDHOOD
POMPE
DISEASE
..................................................................
90
7.3.
DIFFERENTIAL
DIAGNOSIS
OF
POMPE
DISEASE
IN
ADULTS
......................................................................
92
7.3.1.
HYPERCKEMIA
...................................................................................................................................
92
7.3.2.
FATIGUE
AND
MYALGIA
.........................................................................................................................
92
7.3.3.
PROXIMAL
AND
AXIAL
MUSCLE
WEAKNESS
...............................................................................................
93
7.3.4.
RIGID
SPINE
SYNDROME
......................................................................................................................
94
7.3.5.
RESPIRATORY
IMPAIRMENT
..................................................................................................................
94
RESPIRATORY
IMPAIRMENT
IN
POMPE
DISEASE
97
8.1.
WEAKNESS
OF
THE
RESPIRATORY
MUSCLE
SYSTEM
IN
POMPE
DISEASE
..................................................
97
8.1.1.
RESPIRATORY
IMPAIRMENT
IN
CLASSIC
INFANTILE
POMPE
DISEASE
............................................................
97
8.1.2.
RESPIRATORY
IMPAIRMENT
IN
ADULT
POMPE
DISEASE
............................................................................
97
8.1.3.
CONSEQUENCES
OF
RESPIRATORY
MUSCLE
WEAKNESS
..............................................................................
98
8.1.4.
THE
COURSE
OF
RESPIRATORY
MUSCLE
WEAKNESS
....................................................................................
99
8.2.
RESPIRATORY
FUNCTION
TESTING
.........................................................................................................
99
8.2.1.
PULMONARY
FUNCTION
TESTS
(PFTS)
......................................................................................................
99
8.2.2.
RESPIRATORY
MUSCLE
FUNCTION
AND
MANOMETRY
................................................................................
99
8.2.3.
POLYSOMNOGRAPHY
.........................................................................................................................
100
8.3.
MANAGEMENT
OF
RESPIRATORY
INSUFFICIENCY
..................................................................................
101
8.3.1.
RESPIRATORY
MUSCLE
TRAINING
(RMT)
.................................................................................................
101
8.3.2.
MECHANICAL
VENTILATION
...................................................................................................................
101
8.3.3.
COUGH
AUGMENTATION
TECHNIQUES
.................................................................................................
102
8.3.4.
RESPIRATORY
FUNCTION
UNDER
ENZYME
REPLACEMENT
THERAPY
...........................................................
102
ENZYME
REPLACEMENT
THERAPY
IN
POMPE
DISEASE
105
9.1.
THE
HISTORY
AND
DEVELOPMENT
OF
ERT
WITH
A
FOCUS
ON
POMPE
DISEASE
...................................
105
9.2.
BASIC
PRINCIPLES
OF
ERT
.................................................................................................................
108
9.3.
ENZYME
REPLACEMENT
THERAPY
IN
INFANTS
..................................................................................
111
9.3.1.
THE
FIRST
TRIALS
.................................................................................................................................
111
9.3.2.
ERT
FOR
INFANTS
AND
CHILDREN
IN
CLINICAL
PRACTICE:
ACHIEVEMENTS
AND
UNMET
MEDICAL
NEEDS
........
114
9.3.3.
DOSING
............................................................................................................................................
116
9.3.4.
CRIM
STATUS
....................................................................................................................................
117
9.3.5.
ANTIBODY
FORMATION
......................................................................................................................
117
9.4.
IMMUNOMODULATION
UNDER
ENZYME
REPLACEMENT
THERAPY
.....................................................
118
9.5.
ENZYME
REPLACEMENT
THERAPY
IN
CHILDREN
................................................................................
122
9.6.
ENZYME
REPLACEMENT
THERAPY
IN
ADULTS
....................................................................................
124
9.6.1.
ALGLUCOSIDASE
ALFA
STUDIES
IN
ADULTS:
LATE
ONSET
TREATMENT
STUDY
(LOTS)
.....................................
124
9.6.2.
ALGLUCOSIDASE
ALFA
STUDIES
IN
ADULTS:
REAL
WORLD
DATA
..................................................................
125
9.6.3.
ALGLUCOSIDASE
ALFA
STUDIES
IN
ADULTS:
1
0-YEAR
DATA
AND
UNMET
NEEDS
..........................................
126
9.6.4.
SECOND
GENERATION
ERT
.................................................................................................................
126
9.7.
GENE
THERAPY
...............................................................................................................................
128
CONTENTS
15
EXERCISE
TRAINING
AND
REHABILITATION
MANAGEMENT
IN
POMPE
DISEASE
141
10.1.
EXERCISE
TRAINING
.........................................................................................................................
141
10.1.1.
EXERCISE
...........................................................................................................................................
141
10.1.2.
EFFECT
OF
ENDURANCE
AND
RESISTANCE
EXERCISE
IN
POMPE
DISEASE
....................................................
142
10.1.3.
EXERCISE
IN
TREATMENT
NAIVE
PATIENTS
.............................................................................................
142
10.1.4.
ADVERSE
EFFECTS
OF
EXERCISE
.............................................................................................................
142
10.2.
REHABILITATION
MANAGEMENT
OF
ADULTS
.........................................................................................
143
10.2.1.
PRESYMPTOMATIC
PATIENTS
.................................................................................................................
143
10.2.2.
AMBULANT
AND
LESS
AFFECTED
PATIENTS
............................................................................................
144
10.2.3.
SEVERELY
AFFECTED
AND
WHEELCHAIR-BOUND
PATIENTS
.......................................................................
144
10.2.4.
THE
NEW
PHENOTYPES.......................................................................................................................
144
10.3.
REHABILITATION
MANAGEMENT
OF
PATIENTS
WITH
CLASSIC
INFANTILE
POMPE
DISEASE
.......................
145
YY
DIETARY
ASPECTS
OF
POMPE
DISEASE
149
11.1.
BODY
MASS
INDEX
AND
BODY
COMPOSITION
..................................................................................
149
11.2.
PROTEIN
DEGRADATION
AND
ENERGY
EXPENDITURE
.............................................................................
150
11.3.
OPTIMAL
COMPOSITION
OF
DIET
IN
POMPE
DISEASE
.........................................................................
151
11.4.
SEPARATE
SUPPLEMENTATION
OF
DIFFERENT AMINO
ACIDS
................................................................
151
11.5.
DIETARY
SUGGESTIONS
FOR
POMPE
PATIENTS
IN
CLINICAL
PRACTICE
......................................................
152
YY
PATIENT
SUPPORT
GROUPS
155
YY
ABBREVIATIONS
158
INDEX
159
|
adam_txt |
CONTENTS
13
CONTENTS
INTRODUCTION
17
1.1.
HISTORY
AND
TERMINOLOGY
.
17
1.2.
POMPE
DISEASE
AS
LYSOSOMAL
GLYCOGEN
STORAGE
DISORDER
.
19
1.3.
EPIDEMIOLOGY
.
20
FROM
GENETIC
DEFECT
TO
CLINICAL
SYMPTOMS
23
2.1.
IN
GENERAL
.
23
2.2.
FROM
THE
GAA
GENE
TO
FUNCTIONAL
LYSOSOMAL
GAA
.
24
2.2.1.
GAA
PRE-MRNA
SPLICING
.
24
2.2.2.
TRANSLATION,
POST-TRANSLATIONAL
PROCESSING
AND
INTRACELLULAR
TRANSPORT
.
25
2.3.
FROM
GAA
DEFICIENCY
TO
CELLULAR
PATHOLOGY
.
27
2.3.1.
GAA
DEFICIENCY
AND
ENSUING
CELLULAR
DAMAGE
.
27
2.3.2.
RESCUE
OF
DAMAGED
MUSCLE
TISSUE
BY
SATELLITE
CELLS
.
29
2.4.
THE
GENOTYPE-PHENOTYPE
CORRELATION
.
29
2.5.
THE
POMPE
VARIANT
DATABASE
AND
THE
POMPE
REGISTRY
.
32
2.6.
SUMMARY
.
33
AUTOPHAGY
AND
ITS
ROLE
IN
THE
PATHOGENESIS
OF
POMPE
DISEASE
38
3.1.
AUTOPHAGY:
BACKGROUND
.
38
3.2.
AUTOPHAGY
IN
POMPE
DISEASE:
FOCUS
ON
SKELETAL
MUSCLE
.
40
3.3.
CONCLUSION
.
43
CLINICAL
SPECTRUM
46
4.1.
CLASSIC
INFANTILE
POMPE
DISEASE
.
46
4.1.1.
CLINICAL
PRESENTATION,
DIAGNOSIS,
AND
NATURAL
COURSE
OF
DISEASE
.
46
4.1.2.
THE
NEW
PHENOTYPE
.
50
4.2.
CHILDHOOD
POMPE
DISEASE
.
53
4.3.
ADULT
POMPE
DISEASE
.
55
4.3.1.
CLINICAL
FINDINGS
.
55
IB
DIAGNOSIS
65
5.1.
CLINICAL
CHEMISTRY
.
65
5.2.
MUSCLE
IMAGING
PROCEDURES
.
66
5.2.1.
INFANTS
AND
CHILDREN
WITH
POMPE
DISEASE.
66
5.2.2.
ADULT
POMPE
DISEASE
.
67
5.3.
EXAMINATION
OF
THE
CEREBRAL
VESSELS
.
69
5.4.
EXAMINATION
OF
CARDIAC
FUNCTION
.
70
5.5.
EXAMINATION
OF
PULMONARY
FUNCTION
.
71
5.6.
ELECTROMYOGRAPHIC
EXAMINATION
.
71
5.7.
MUSCLE
BIOPSY
.
71
5.8.
MEASUREMENT
OF
ENZYME
ACTIVITY
.
74
5.9.
DNA
ANALYSIS
.
75
14
CONTENTS
PRENATAL
DIAGNOSIS,
POPULATION
SCREENING
AND
COUNSELLING
82
6.1.
INTRODUCTION
.
82
6.2.
PRENATAL
DIAGNOSIS
.
82
6.3.
PREIMPLANTATION
GENETIC
TESTING
(PGT)
.
83
6.4.
NEWBORN
AND
POPULATION
SCREENING
.
84
DIFFERENTIAL
DIAGNOSIS
OF
POMPE
DISEASE
88
7.1.
DIFFERENTIAL
DIAGNOSIS
OF
CLASSIC
INFANTILE
POMPE
DISEASE
.
88
7.2.
DIFFERENTIAL
DIAGNOSIS
OF
CHILDHOOD
POMPE
DISEASE
.
90
7.3.
DIFFERENTIAL
DIAGNOSIS
OF
POMPE
DISEASE
IN
ADULTS
.
92
7.3.1.
HYPERCKEMIA
.
92
7.3.2.
FATIGUE
AND
MYALGIA
.
92
7.3.3.
PROXIMAL
AND
AXIAL
MUSCLE
WEAKNESS
.
93
7.3.4.
RIGID
SPINE
SYNDROME
.
94
7.3.5.
RESPIRATORY
IMPAIRMENT
.
94
RESPIRATORY
IMPAIRMENT
IN
POMPE
DISEASE
97
8.1.
WEAKNESS
OF
THE
RESPIRATORY
MUSCLE
SYSTEM
IN
POMPE
DISEASE
.
97
8.1.1.
RESPIRATORY
IMPAIRMENT
IN
CLASSIC
INFANTILE
POMPE
DISEASE
.
97
8.1.2.
RESPIRATORY
IMPAIRMENT
IN
ADULT
POMPE
DISEASE
.
97
8.1.3.
CONSEQUENCES
OF
RESPIRATORY
MUSCLE
WEAKNESS
.
98
8.1.4.
THE
COURSE
OF
RESPIRATORY
MUSCLE
WEAKNESS
.
99
8.2.
RESPIRATORY
FUNCTION
TESTING
.
99
8.2.1.
PULMONARY
FUNCTION
TESTS
(PFTS)
.
99
8.2.2.
RESPIRATORY
MUSCLE
FUNCTION
AND
MANOMETRY
.
99
8.2.3.
POLYSOMNOGRAPHY
.
100
8.3.
MANAGEMENT
OF
RESPIRATORY
INSUFFICIENCY
.
101
8.3.1.
RESPIRATORY
MUSCLE
TRAINING
(RMT)
.
101
8.3.2.
MECHANICAL
VENTILATION
.
101
8.3.3.
COUGH
AUGMENTATION
TECHNIQUES
.
102
8.3.4.
RESPIRATORY
FUNCTION
UNDER
ENZYME
REPLACEMENT
THERAPY
.
102
ENZYME
REPLACEMENT
THERAPY
IN
POMPE
DISEASE
105
9.1.
THE
HISTORY
AND
DEVELOPMENT
OF
ERT
WITH
A
FOCUS
ON
POMPE
DISEASE
.
105
9.2.
BASIC
PRINCIPLES
OF
ERT
.
108
9.3.
ENZYME
REPLACEMENT
THERAPY
IN
INFANTS
.
111
9.3.1.
THE
FIRST
TRIALS
.
111
9.3.2.
ERT
FOR
INFANTS
AND
CHILDREN
IN
CLINICAL
PRACTICE:
ACHIEVEMENTS
AND
UNMET
MEDICAL
NEEDS
.
114
9.3.3.
DOSING
.
116
9.3.4.
CRIM
STATUS
.
117
9.3.5.
ANTIBODY
FORMATION
.
117
9.4.
IMMUNOMODULATION
UNDER
ENZYME
REPLACEMENT
THERAPY
.
118
9.5.
ENZYME
REPLACEMENT
THERAPY
IN
CHILDREN
.
122
9.6.
ENZYME
REPLACEMENT
THERAPY
IN
ADULTS
.
124
9.6.1.
ALGLUCOSIDASE
ALFA
STUDIES
IN
ADULTS:
LATE
ONSET
TREATMENT
STUDY
(LOTS)
.
124
9.6.2.
ALGLUCOSIDASE
ALFA
STUDIES
IN
ADULTS:
REAL
WORLD
DATA
.
125
9.6.3.
ALGLUCOSIDASE
ALFA
STUDIES
IN
ADULTS:
1
0-YEAR
DATA
AND
UNMET
NEEDS
.
126
9.6.4.
SECOND
GENERATION
ERT
.
126
9.7.
GENE
THERAPY
.
128
CONTENTS
15
EXERCISE
TRAINING
AND
REHABILITATION
MANAGEMENT
IN
POMPE
DISEASE
141
10.1.
EXERCISE
TRAINING
.
141
10.1.1.
EXERCISE
.
141
10.1.2.
EFFECT
OF
ENDURANCE
AND
RESISTANCE
EXERCISE
IN
POMPE
DISEASE
.
142
10.1.3.
EXERCISE
IN
TREATMENT
NAIVE
PATIENTS
.
142
10.1.4.
ADVERSE
EFFECTS
OF
EXERCISE
.
142
10.2.
REHABILITATION
MANAGEMENT
OF
ADULTS
.
143
10.2.1.
PRESYMPTOMATIC
PATIENTS
.
143
10.2.2.
AMBULANT
AND
LESS
AFFECTED
PATIENTS
.
144
10.2.3.
SEVERELY
AFFECTED
AND
WHEELCHAIR-BOUND
PATIENTS
.
144
10.2.4.
THE
NEW
PHENOTYPES.
144
10.3.
REHABILITATION
MANAGEMENT
OF
PATIENTS
WITH
CLASSIC
INFANTILE
POMPE
DISEASE
.
145
YY
DIETARY
ASPECTS
OF
POMPE
DISEASE
149
11.1.
BODY
MASS
INDEX
AND
BODY
COMPOSITION
.
149
11.2.
PROTEIN
DEGRADATION
AND
ENERGY
EXPENDITURE
.
150
11.3.
OPTIMAL
COMPOSITION
OF
DIET
IN
POMPE
DISEASE
.
151
11.4.
SEPARATE
SUPPLEMENTATION
OF
DIFFERENT AMINO
ACIDS
.
151
11.5.
DIETARY
SUGGESTIONS
FOR
POMPE
PATIENTS
IN
CLINICAL
PRACTICE
.
152
YY
PATIENT
SUPPORT
GROUPS
155
YY
ABBREVIATIONS
158
INDEX
159 |
any_adam_object | 1 |
any_adam_object_boolean | 1 |
author | Reuser, Arnold J.J Schoser, Benedikt |
author_GND | (DE-588)1258294966 (DE-588)17274007X |
author_facet | Reuser, Arnold J.J Schoser, Benedikt |
author_role | aut aut |
author_sort | Reuser, Arnold J.J |
author_variant | a j r aj ajr b s bs |
building | Verbundindex |
bvnumber | BV048488156 |
ctrlnum | (OCoLC)1347224938 (DE-599)DNB1252089473 |
dewey-full | 616.3998 |
dewey-hundreds | 600 - Technology (Applied sciences) |
dewey-ones | 616 - Diseases |
dewey-raw | 616.3998 |
dewey-search | 616.3998 |
dewey-sort | 3616.3998 |
dewey-tens | 610 - Medicine and health |
discipline | Medizin |
discipline_str_mv | Medizin |
edition | 3rd edition |
format | Book |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02611nam a2200577 c 4500</leader><controlfield tag="001">BV048488156</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">220927s2021 gw a||| |||| 00||| eng d</controlfield><datafield tag="015" ind1=" " ind2=" "><subfield code="a">22,N08</subfield><subfield code="2">dnb</subfield></datafield><datafield tag="015" ind1=" " ind2=" "><subfield code="a">22,A23</subfield><subfield code="2">dnb</subfield></datafield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">1252089473</subfield><subfield code="2">DE-101</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9783837424331</subfield><subfield code="c">Festeinband : EUR 4.95 (DE), EUR 5.10 (AT), CHF 9.40 (freier Preis)</subfield><subfield code="9">978-3-8374-2433-1</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">3837424332</subfield><subfield code="9">3-8374-2433-2</subfield></datafield><datafield tag="024" ind1="3" ind2=" "><subfield code="a">9783837424331</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1347224938</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DNB1252089473</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">gw</subfield><subfield code="c">XA-DE-HB</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-19</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">616.3998</subfield><subfield code="2">23/ger</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="8">1\p</subfield><subfield code="a">610</subfield><subfield code="2">23sdnb</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Reuser, Arnold J.J.</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)1258294966</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Pompe Disease</subfield><subfield code="c">Arnold J.J. Reuser, Benedikt Schoser ; in collaboration with Atze J. Bergsma, Nadine A.M.E. van der Beek, Linda E.M. van den Berg, Alexander Broomfield, Esther Brusse [und weiteren]</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">3rd edition</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Bremen</subfield><subfield code="b">UNI-MED</subfield><subfield code="c">2021</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">160 Seiten</subfield><subfield code="b">Illustrationen</subfield><subfield code="c">25 cm, 450 g</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">UNI-MED Science</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Typ 2</subfield><subfield code="0">(DE-588)4326601-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Glykogenose</subfield><subfield code="0">(DE-588)4157737-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Morbus Pompe</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Pompe Disease</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">lysosomal storage disorder</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Morbus Pompe;Pompe Disease;lysosomal storage disorder</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Glykogenose</subfield><subfield code="0">(DE-588)4157737-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Typ 2</subfield><subfield code="0">(DE-588)4326601-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Schoser, Benedikt</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)17274007X</subfield><subfield code="4">aut</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">UNI-MED Verlag AG</subfield><subfield code="0">(DE-588)1065561733</subfield><subfield code="4">pbl</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Online-Ausgabe</subfield><subfield code="a">Reuser, Arnold J.J.</subfield><subfield code="t">Pompe Disease</subfield><subfield code="b">3rd edition</subfield><subfield code="d">Bremen : UNI-MED Verlag AG, 2022</subfield><subfield code="h">Online-Ressource, 161 Seiten, 64 Illustrationen</subfield></datafield><datafield tag="780" ind1="0" ind2="0"><subfield code="i">Vorangegangen ist</subfield><subfield code="z">9783837413977</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">X:MVB</subfield><subfield code="q">text/html</subfield><subfield code="u">http://deposit.dnb.de/cgi-bin/dokserv?id=40337a9757cc4b7cbf2dbceb2a6069ff&prov=M&dok_var=1&dok_ext=htm</subfield><subfield code="3">Inhaltstext</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">B:DE-101</subfield><subfield code="q">application/pdf</subfield><subfield code="u">https://d-nb.info/1252089473/04</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">DNB Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=033865687&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-033865687</subfield></datafield><datafield tag="883" ind1="2" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">dnb</subfield><subfield code="d">20220530</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#dnb</subfield></datafield></record></collection> |
id | DE-604.BV048488156 |
illustrated | Illustrated |
index_date | 2024-07-03T20:40:50Z |
indexdate | 2024-07-10T09:39:28Z |
institution | BVB |
institution_GND | (DE-588)1065561733 |
isbn | 9783837424331 3837424332 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-033865687 |
oclc_num | 1347224938 |
open_access_boolean | |
owner | DE-19 DE-BY-UBM |
owner_facet | DE-19 DE-BY-UBM |
physical | 160 Seiten Illustrationen 25 cm, 450 g |
publishDate | 2021 |
publishDateSearch | 2021 |
publishDateSort | 2021 |
publisher | UNI-MED |
record_format | marc |
series2 | UNI-MED Science |
spelling | Reuser, Arnold J.J. Verfasser (DE-588)1258294966 aut Pompe Disease Arnold J.J. Reuser, Benedikt Schoser ; in collaboration with Atze J. Bergsma, Nadine A.M.E. van der Beek, Linda E.M. van den Berg, Alexander Broomfield, Esther Brusse [und weiteren] 3rd edition Bremen UNI-MED 2021 160 Seiten Illustrationen 25 cm, 450 g txt rdacontent n rdamedia nc rdacarrier UNI-MED Science Typ 2 (DE-588)4326601-0 gnd rswk-swf Glykogenose (DE-588)4157737-1 gnd rswk-swf Morbus Pompe Pompe Disease lysosomal storage disorder Morbus Pompe;Pompe Disease;lysosomal storage disorder Glykogenose (DE-588)4157737-1 s Typ 2 (DE-588)4326601-0 s DE-604 Schoser, Benedikt Verfasser (DE-588)17274007X aut UNI-MED Verlag AG (DE-588)1065561733 pbl Erscheint auch als Online-Ausgabe Reuser, Arnold J.J. Pompe Disease 3rd edition Bremen : UNI-MED Verlag AG, 2022 Online-Ressource, 161 Seiten, 64 Illustrationen Vorangegangen ist 9783837413977 X:MVB text/html http://deposit.dnb.de/cgi-bin/dokserv?id=40337a9757cc4b7cbf2dbceb2a6069ff&prov=M&dok_var=1&dok_ext=htm Inhaltstext B:DE-101 application/pdf https://d-nb.info/1252089473/04 Inhaltsverzeichnis DNB Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=033865687&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis 1\p dnb 20220530 DE-101 https://d-nb.info/provenance/plan#dnb |
spellingShingle | Reuser, Arnold J.J Schoser, Benedikt Pompe Disease Typ 2 (DE-588)4326601-0 gnd Glykogenose (DE-588)4157737-1 gnd |
subject_GND | (DE-588)4326601-0 (DE-588)4157737-1 |
title | Pompe Disease |
title_auth | Pompe Disease |
title_exact_search | Pompe Disease |
title_exact_search_txtP | Pompe Disease |
title_full | Pompe Disease Arnold J.J. Reuser, Benedikt Schoser ; in collaboration with Atze J. Bergsma, Nadine A.M.E. van der Beek, Linda E.M. van den Berg, Alexander Broomfield, Esther Brusse [und weiteren] |
title_fullStr | Pompe Disease Arnold J.J. Reuser, Benedikt Schoser ; in collaboration with Atze J. Bergsma, Nadine A.M.E. van der Beek, Linda E.M. van den Berg, Alexander Broomfield, Esther Brusse [und weiteren] |
title_full_unstemmed | Pompe Disease Arnold J.J. Reuser, Benedikt Schoser ; in collaboration with Atze J. Bergsma, Nadine A.M.E. van der Beek, Linda E.M. van den Berg, Alexander Broomfield, Esther Brusse [und weiteren] |
title_short | Pompe Disease |
title_sort | pompe disease |
topic | Typ 2 (DE-588)4326601-0 gnd Glykogenose (DE-588)4157737-1 gnd |
topic_facet | Typ 2 Glykogenose |
url | http://deposit.dnb.de/cgi-bin/dokserv?id=40337a9757cc4b7cbf2dbceb2a6069ff&prov=M&dok_var=1&dok_ext=htm https://d-nb.info/1252089473/04 http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=033865687&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
work_keys_str_mv | AT reuserarnoldjj pompedisease AT schoserbenedikt pompedisease AT unimedverlagag pompedisease |